News Home

PAVmed Inc (PAVM) Stock: Do Analysts Think You Should Buy?

Wednesday, December 08, 2021 10:47 AM | InvestorsObserver Analysts
PAVmed Inc (PAVM) Stock: Do Analysts Think You Should Buy?

Analysts who follow PAVmed Inc (PAVM) on average expect it to climb 151.40% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. That average rating earns PAVmed Inc an Analyst Ranking of 74, which means it ranks higher than 74 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 5
Wall Street analysts are rating PAVM a Strong Buy today. Find out what this means to you and get the rest of the rankings on PAVM!

Why are Analyst Ratings Important?

Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported. InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.

What's Happening With PAVmed Inc Stock Today?

PAVmed Inc (PAVM) stock has risen 3.32% while the S&P 500 has fallen -0.08% as of 10:45 AM on Wednesday, Dec 8. PAVM has gained $0.12 from the previous closing price of $3.46 on volume of 267,861 shares. Over the past year the S&P 500 has risen 26.48% while PAVM has gained 84.54%. PAVM lost -$0.58 per share the over the last 12 months. Click Here to get the full Stock Report for PAVmed Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App